Drug synthesis includes (a) a component that induces the release of intestinal hormones from selected cells, including butyric acid, cholic acid, long-chain fatty acids and glutamic acid； and (b) a DPP-IV inhibitor, where (a) and (b) are managed. At the same time, I can also use diabetes.
The present invention relates to a method of treating diabetes type II by delivery of butyric acid, bile acid, long chain fatty acid or glutamine to the colon by bypassing the upper digestive tract. The composition is combined either by the same or different route of administration with a DPP-IV inhibitor such as vildagliptin.COMPOSICION FARMACEUTICA QUE COMPRENDE A) UNA COMPOSICION PARA INDUCIR LA LIBERACION DE UNA HORMONA INTESTINAL DESDE LA CELULA L SELECCIONADA DEL GRUPO QUE COMPRENDE ACIDO BUTIRICO, UN ACIDO BILIAR, UN ACIDO GRASO DE CADENA LARGA Y GLUTAMINA； Y B) UN INHIBIDOR DE DPP-IV, DONDE A) Y B) SE ADMINISTRAN SIMULTANEAMENTE, UTIL EN DIABETES.
